Evidence map›Paper›PMID 27799222›Full record

ArticleAntimicrobial agents and chemotherapy2017

Competitive Growth Enhances Conditional Growth Mutant Sensitivity to Antibiotics and Exposes a Two-Component System as an Emerging Antibacterial Target in Burkholderia cenocepacia.

April S Gislason, Matthew Choy, Ruhi A M Bloodworth, Wubin Qu, Maria S Stietz, Xuan Li, Chenggang Zhang, Silvia T Cardona

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Multistep Signaling in Nature: A Close-Up ofInternational journal of molecular sciences · 2021
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Frontiers in microbiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

April S GislasonDepartment of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Matthew ChoyDepartment of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Ruhi A M BloodworthDepartment of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Wubin QuBeijing Institute of Radiation Medicine, State Key Laboratory of Proteomics, Cognitive and Mental Health Research Center, Beijing, China.
Maria S StietzDepartment of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Xuan LiDepartment of Mathematics and Statistics, University of Minnesota Duluth, Duluth, Minnesota, USA.
Chenggang ZhangBeijing Institute of Radiation Medicine, State Key Laboratory of Proteomics, Cognitive and Mental Health Research Center, Beijing, China.
Silvia T CardonaDepartment of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada Silvia.Cardona@umanitoba.ca.ORCID 0000-0002-0629-8886

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemogenetic approaches to profile an antibiotic mode of action are based on detecting differential sensitivities of engineered bacterial strains in which the antibacterial target (usually encoded by an essential gene) or an associated process is regulated. We previously developed an essential-gene knockdown mutant library in the multidrug-resistant Burkholderia cenocepacia by transposon delivery of a rhamnose-inducible promoter. In this work, we used Illumina sequencing of multiplex-PCR-amplified transposon junctions to track individual mutants during pooled growth in the presence of antibiotics. We found that competition from nontarget mutants magnified the hypersensitivity of a clone underexpressing gyrB to novobiocin by 8-fold compared with hypersensitivity measured during clonal growth. Additional profiling of various antibiotics against a pilot library representing most categories of essential genes revealed a two-component system with unknown function, which, upon depletion of the response regulator, sensitized B. cenocepacia to novobiocin, ciprofloxacin, tetracycline, chloramphenicol, kanamycin, meropenem, and carbonyl cyanide 3-chlorophenylhydrazone, but not to colistin, hydrogen peroxide, and dimethyl sulfoxide. We named the gene cluster esaSR for enhanced sensitivity to antibiotics sensor and response regulator. Mutational analysis and efflux activity assays revealed that while esaS is not essential and is involved in antibiotic-induced efflux, esaR is an essential gene and regulates efflux independently of antibiotic-mediated induction. Furthermore, microscopic analysis of cells stained with propidium iodide provided evidence that depletion of EsaR has a profound effect on the integrity of cell membranes. In summary, we unraveled a previously uncharacterized two-component system that can be targeted to reduce antibiotic resistance in B. cenocepacia.

Indexed as

Anti-Bacterial AgentsBurkholderia cenocepaciaChloramphenicolCiprofloxacinDrug Resistance, Multiple, BacterialHydrazonesKanamycinMeropenemMicrobial Sensitivity TestsNovobiocinTetracyclineThienamycinsAnti-Bacterial Agentscarbonyl 3-chlorophenylhydrazoneChloramphenicolCiprofloxacinHydrazonesKanamycinMeropenemNovobiocinTetracyclineThienamycinsantibiotic profilingantibiotic resistanceBurkholderiadrug effluxdrug targetsessential genesGram-negative bacteriaIlluminatransposon mutanttwo-component regulatory systems

Identifiers

PMID27799222
PMCPMC5192132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.